Dermatological Diseases
%22%20%2F%3E%3C%2Fsvg%3E)
We compared psoriasis severity scores when advanced therapy was prescribed, scores at follow-up, treatment response, and delay between prescription and first dose in public vs private drug insurance groups.
%22%20%2F%3E%3C%2Fsvg%3E)
We assessed healthcare resource utilization and all-cause direct healthcare costs, including out-of-pocket costs, of US adolescents with alopecia areata.
%22%20%2F%3E%3C%2Fsvg%3E)
Interleukin-23 (IL-23) has emerged as a key player in the pathogenesis of psoriasis and tildrakizumab and guselkumab are both immunomodulatory agents that inhibit the p19 subunit of IL-23.
%22%20%2F%3E%3C%2Fsvg%3E)
We evaluated patient preferences for attributes of psoriasis treatments, including efficacy, tolerability, and mode and frequency of administration.
We estimate the value of ingenol mebutate gel’s shorter treatment duration and tolerability profile to potential patients, versus existing topical treatments in the United States.